Possibly a better approach to promote Afrezza
Jan 10, 2016 4:01:30 GMT -5
sportsrancho and chc like this
Post by careful2invest on Jan 10, 2016 4:01:30 GMT -5
Unfortunately, I cannot take credit for being the creator of this genious plan, (Lorcan from ymb) but I can forward it to the masses adding as I saw fit.
It really makes sense!
The new approach to marketing Afrezza...
I think a huge mistake was made marketing it as an inhaled insulin. The marketing needs to be changed to say that it is the one and only monomer insulin available, oh and it's also inhalable so you don't have to stab needles in through your skin. Exubera was marketed as inhalable because that was the only difference. Afrezza's monomer properties are what really differentiate it.
Here's a tagline for a better ad campaign:
"There are only two ways to get monomer insulin. A healthy pancreas or a prescription for Afrezza. Either way, you won't be needing any needles."
If a professional advertising company were to impliment this concept into a new plan of promoting Afrezza (especially to MD's at first)
It would lessen the automatic (negative) connection to Exhubera, and place the emphasis on how AFREZZA performs, which is
unlike any other insulin ever produced by man! That alone says it all!!
Afrezza is worthy of blockbuster status!
Promoting Afrezza properly is key!
Hopefully, Mr. DeSisto is prepared for this task!
GLTA
It really makes sense!
The new approach to marketing Afrezza...
I think a huge mistake was made marketing it as an inhaled insulin. The marketing needs to be changed to say that it is the one and only monomer insulin available, oh and it's also inhalable so you don't have to stab needles in through your skin. Exubera was marketed as inhalable because that was the only difference. Afrezza's monomer properties are what really differentiate it.
Here's a tagline for a better ad campaign:
"There are only two ways to get monomer insulin. A healthy pancreas or a prescription for Afrezza. Either way, you won't be needing any needles."
If a professional advertising company were to impliment this concept into a new plan of promoting Afrezza (especially to MD's at first)
It would lessen the automatic (negative) connection to Exhubera, and place the emphasis on how AFREZZA performs, which is
unlike any other insulin ever produced by man! That alone says it all!!
Afrezza is worthy of blockbuster status!
Promoting Afrezza properly is key!
Hopefully, Mr. DeSisto is prepared for this task!
GLTA